Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2018.2008
Abstract: Key Points Question Are reductions in cardiovascular disease risk produced by financial incentives placed on patients, physicians, or both to control low-density lipoprotein cholesterol levels worth the costs needed to achieve these health benefits? Findings… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24787
Abstract: To examine the association between low‐density lipoprotein cholesterol (LDL‐C) concentrations and the risk of a large hematoma volume after intracerebral hemorrhage (ICH). read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Current Diabetes Reports"
DOI: 10.1007/s11892-019-1246-y
Abstract: To review randomized interventional clinical and imaging trials that support lower targeted atherogenic lipoprotein cholesterol goals in “extreme” and “very high” atherosclerotic cardiovascular disease (ASCVD) risk settings. Major atherosclerotic cardiovascular event (MACE) prevention among the… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Endocrine"
DOI: 10.1007/s12020-018-1685-2
Abstract: PurposeThe most commonly used method for estimating low-density lipoprotein cholesterol (LDLC) is Friedewald formula (FF). This study aims to extract and validate new modified Friedewald formulae for estimating LDLC according to triglyceride (TG) levels in… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "American Heart Journal"
DOI: 10.1016/j.ahj.2016.10.013
Abstract: Background Knowledge about lipid interventions in secondary prevention in HIV‐infected individuals is limited; studies are sparse. Methods A prospective observational multicenter study enrolled 282 patients on statin 1 month after first acute coronary syndrome (ACS)… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "American heart journal"
DOI: 10.1016/j.ahj.2019.11.005
Abstract: BACKGROUND Type 2 diabetes (T2D) patients are at increased risk for cardiovascular (CV) events. Most guidelines recommend treating low-density lipoprotein cholesterol (LDL-C) levels to ≤70 mg/dL (1.8 mM) for patients with T2D and established atherosclerotic… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2017.11.020
Abstract: BACKGROUND AND AIMS Elevated low-density lipoprotein cholesterol (LDL-C) is a causal risk factor for cardiovascular (CV) events. European guidelines recommend reducing LDL-C as the primary lipid target to reduce CV risk, using lifestyle modifications and… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Current problems in cardiology"
DOI: 10.1016/j.cpcardiol.2022.101153
Abstract: Hypercholesterolemia is a significant risk factor for heart disease. The soluble fiber in oat (Avena sativa L.), beta-glucan has been shown to significantly lower serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels but… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Diabetes research and clinical practice"
DOI: 10.1016/j.diabres.2021.108858
Abstract: AIMS Atherogenic dyslipidemia, associated with small, dense low-density lipoprotein-cholesterol (S-LDL) particles and impaired metabolism of triglycerides (TGs) and high-density lipoprotein-cholesterol (HDL-c), leads to the development of atherosclerosis-related complications of type 2 diabetes mellitus. Based on… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2019.07.007
Abstract: Background High circulating low-density lipoprotein cholesterol (LDL-C) is a major risk factor for atherosclerosis and age-associated cardiovascular events. Long-term dyslipidaemia could contribute to the development of frailty in older individuals through its role in determining… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Indian Heart Journal"
DOI: 10.1016/j.ihj.2017.01.007
Abstract: Low density Lipoprotein Cholesterol (LDLc) is considered as a major risk factor in the development of cardiovascular disease and is the primary basis for diagnosis, treatment and risk classification in patients with hyperlipidemia. This makes… read more here.